SPY330.65-3.85 -1.15%
DIA276.52-2.38 -0.85%
IXIC10,793.28-117.00 -1.07%

Canaccord Genuity Maintains Buy on ChemoCentryx, Raises Price Target to $68

Canaccord Genuity maintains ChemoCentryx (NASDAQ:CCXI) with a Buy and raises the price target from $64 to $68.

Benzinga · 05/12/2020 16:20

Canaccord Genuity maintains ChemoCentryx (NASDAQ:CCXI) with a Buy and raises the price target from $64 to $68.